Apollo Endosurgery Names Former Covidien Chairman and CEO Richard J. Meelia to Board of Directors
Apollo Endosurgery, Inc., a company focused on the development of
devices that advance therapeutic endoscopy to enable an entirely new
generation of endoscopic surgical procedures, today announced that
Richard J. Meelia, former CEO and Chairman of Covidien plc, will be
joining the company's Board of Directors.
"Apollo Endosurgery has the potential to lead a fundamental change in
patient care in gastrointestinal surgery, including the important
areas of gastrointestinal cancer and bariatrics," Meelia said. "The
company is at the forefront of endoscopic surgery, a field that
combines the therapeutic benefits of surgery with the minimally
invasive advantages of flexible endoscopy. By aligning itself with the
top international experts in the field of minimally invasive surgery
and medical devices, Apollo Endosurgery will continue to enable
surgeons and gastroenterologists to offer less invasive treatment
options and excellent patient care."
Meelia will fill a newly-created seat on the Apollo Endosurgery board,
joining Dennis L. McWilliams, the founder, President and CEO of Apollo
Endosurgery; Matthew S. Crawford, Founding Managing Director of PTV
Sciences; Bruce Roberson, Ph.D., Managing Director of H.I.G.
BioVentures; Jack Nielsen, Partner, Novo A/S; John Creecy, CEO of
Remeditex; and R. Kent McGaughy, Jr., Managing Director of CPMG, Inc.
Meelia's appointment will be effective July 1, 2012.
Meelia recently retired from his position as Chairman and CEO of
Covidien, a leading global healthcare products company. He led
Covidien's spinoff from Tyco in 2007 where he had served as President
of Tyco Healthcare since 1995. During his tenure at Tyco Healthcare
and Covidien, Meelia directed the company's integration and product
development efforts, growing the business from $600 million in sales
to over $10 billion by 2010. Prior to joining Tyco Healthcare, Meelia
was President of Infusaid, Inc., a division of Pfizer Hospital
Products Group. He also held sales and marketing positions with the
Pharmaseal and McGaw divisions of the American Hospital Supply
Corporation. Meelia holds an MBA from Boston College and an
undergraduate degree from Saint Anselm College.
Mr. Meelia is also a member of the Board of Directors of Triangle,
Inc., a career empowerment network for people with disabilities as
well as Chairman of the Board of Haeomonetics, a company that develops
processes to help hospitals and blood banks efficiently and safely
manage blood supplies. He also serves on the Board of Governors of the
Tufts-New England Medical Center and the Board of Trustees of St.
"We are pleased to leverage Rich's years of experience as the Chairman
and CEO of one of the world's largest surgical supplies and medical
device makers. Rich has a valuable track record of leadership in
company growth and a deep knowledge of the medical device, hospital
and surgical supply industries," McWilliams said. "Rich's commitment
to Apollo Endosurgery will complement and enhance our position as an
innovator and a driving force in advancing this new class of less
invasive endoscopic surgery devices and procedures. We welcome him to
About Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc. is dedicated to revolutionizing patient care
through the advancement of endoscopic surgery, which is emerging from
the convergence of laparoscopic surgery and therapeutic endoscopy.
Endoscopic surgery minimizes the trauma of surgical access by taking
advantage of natural orifices to deliver surgical tools to targeted
areas. All of Apollo's products are compatible with existing flexible
endoscope platforms. Apollo Endosurgery was cofounded with the Apollo
Group, a unique collaboration of physicians from the Mayo Clinic,
Johns Hopkins University, Medical University of South Carolina, the
University of Texas Medical Branch and the Chinese University of Hong
Kong. This collaboration developed a broad portfolio of patents in the
field of endoscopic surgery that became the foundation of Apollo
Endosurgery. The company has also received a grant from the Cancer
Prevention Research Institute of Texas.
Apollo Endosurgery, OverStitch? and SuMO? are either registered
trademarks or trademarks of Apollo Endosurgery, Inc. in the US and/or